Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase in minor ischemic stroke (TEMPO-2)
NCT02398656Phase 3Completed
- Sponsor
- University of Calgary
- Start
- Apr 2015
- Primary completion
- Jan 2024
- Countries
- 10
01
Overview
A Phase 3 trial of tenecteplase in acute ischemic stroke (AIS), sponsored by University of Calgary. Started Apr 2015; status: completed.
02
Drugs
tenecteplase
03
Conditions
acute ischemic stroke (AIS)
Beyond the preview
Go deeper on NCT02398656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02398656.